Connect with us

Now

Establishing Russian Industrial Zone in Egypt comes into force

Published

on

CAIRO – 1 February 2019: President Abdel Fatah Al Sisi issued decree No. 420 of 2018 approving an agreement between the governments of Egypt and Russia concerning the establishment and operation of the Russian Industrial Zone in the Suez Canal Economic Zone in Egypt, which was signed in Moscow on May 23, 2018.

The decree was published in the official gazette Al-Waqa’i’ al-Misriyya on Jan. 23, 2019. As per the Egyptian constitution, any presidential decree shall be published in the official gazette to come into force.

Since February 2015, Egypt and Russia have been negotiating $7 billion worth of Russian investments in the Russian Industrial Zone (RIZ) project in the East Port Said region.

RIZ would be established on an area of 5.25 million square meters and will be built over three phases, according to a statement issued by the Suez Canal Economic Zone.

The project will be conducted on three phases, the first phase involves 1 million square meters, will be carried out by a Russian developer who will also work on attracting Russian investors and companies throughout 2018 and 2019. This phase will create 7,300 jobs in the construction field.

The second phase will develop 1.6 million square meters and will be finished by 2022, creating 10,000 jobs, while the third phase will develop 2.65 million square meters and generate 17,000 jobs.

The three phases are expected to be finished by 2031, when Russian companies will start operations, providing some 35,000 direct and indirect jobs, the statement said.

It's Just me, Akram Moftah typical cancer radio announcer crazy about cinema, photography, videography, soccer, Radio, internet, marketing, cars.

Now

AstraZeneca COVID-19 vaccine Shows 90% Effectiveness With No Serious Side Effects

Published

on

By

AstraZeneca announced today the effectiveness of its Covid-19 vaccine and it turned out to be around 90% effective with no serious side effects!

According to data from the late-stage trials in Britain and Brazil, the vaccine, which is developed by Oxford University, has shown 90% effectiveness after being administered as a a half dose followed by a full dose at least one month apart.

“This vaccine’s efficacy and safety confirm that it will be highly effective against COVID-19 and will have an immediate impact on this public health emergency,” Pascal Soriot, Astra’s chief executive, said in a statement.

British Prime minister Boris Johnson said it was “incredibly exciting news the Oxford vaccine has proved so effective in trials.”

The next step now is for the company to start preparing regulatory submission of the data to authorities across the world that have a framework in place for conditional or early approval.

It will also seek an emergency use listing from the World Health Organization (WHO) to speed up availability in countries with low income. In parallel, the full analysis of the interim results is being submitted for publication in a peer-reviewed journal.

With both Oxford’s and Pfizer’s vaccines, we can be hopeful that the new year will come bearing good news!

Continue Reading

Now

Another Coronavirus Vaccine By Moderna Shows 94.5% Effectiveness!

Published

on

By

Yet another promising news for a Covid-19 vaccine has been announced! Moderna said today that its vaccine has shown 94.5% effectiveness in preventing the virus, according to an analysis of its clinical trial.

The biotech company made the announcement earlier today, giving us a dash of hope amidst this coronavirus scare.

The news follows the announcement made by Pfizer and BioNTech, who said their vaccine was more than 90% effective.

The results come from interim analyses of intensive clinical studies. The clinical trials of Moderna saw the participation of 30,000 volunteers. Half got two doses of the vaccine 28 days apart, half got two shots of a placebo on the same schedule.

“This positive interim analysis from our Phase 3 study has given us the first clinical validation that our vaccine can prevent COVID-19 disease, including severe disease,” said Stéphane Bancel, chief executive officer of Moderna, in a statement.

Both companies used the same technology in making the vaccines, which is a tech based on a molecule known as mRNA, or messenger RNA. That molecule contains genetic instructions for making proteins inside cells.

We hope that by the end of this year, we can rest assured that a vaccine can soon end this pandemic.

Continue Reading

Now

Hopes Rise As Pfizer Announces That Its COVID-19 Vaccine is 90% Effective

Published

on

By

Hope rises as pharmaceutical giant Pfizer announced that its COVID-19 vaccine has successfully prevented 90% of the virus, a promising result that exceeded experts’ expectations!

This analysis is based on 94 cases of infection with SARS-CoV-2, the virus responsible for causing COVID-19, among both the vaccinated and placebo groups. The results included data from 38,955 of the total 43,538 volunteers who enrolled.

This makes Pfizer the very first company to release results from its Covid-19 vaccine, these findings are a result of collected seven days after the second of Pfizer’s two-shot regimen.

 

 

Continue Reading
Event calender
Cinema calender

Cinema calender

Facebook

Fashion

Categories

Top Posts

Trending

X